- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic lupus erythematosus
Authors
Keywords
-
Journal
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
Volume -, Issue -, Pages 101814
Publisher
Elsevier BV
Online
2023-01-25
DOI
10.1016/j.berh.2022.101814
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
- (2022) Richard A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
- (2022) Yoshiya Tanaka et al. Nature Reviews Rheumatology
- Treat-to-target in systemic lupus erythematosus: advancing towards its implementation
- (2022) Agner R. Parra Sánchez et al. Nature Reviews Rheumatology
- Expert Perspective: An Approach to Refractory Lupus Nephritis
- (2022) Swati Arora et al. Arthritis & Rheumatology
- Biological impact of iberdomide in patients with active systemic lupus erythematosus
- (2022) Peter E Lipsky et al. ANNALS OF THE RHEUMATIC DISEASES
- Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus
- (2022) Joan T. Merrill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
- (2022) Victoria P. Werth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
- (2022) Richard A. Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bite of the wolf: innate immune responses propagate autoimmunity in lupus
- (2021) Sarthak Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
- (2021) Yusuke Miyazaki et al. RHEUMATOLOGY
- 2021 DORIS definition of remission in SLE: final recommendations from an international task force
- (2021) Ronald F van Vollenhoven et al. Lupus Science & Medicine
- State‐of‐the‐art treatment of systemic lupus erythematosus
- (2020) Yoshiya Tanaka International Journal of Rheumatic Diseases
- Autoimmunity and organ damage in systemic lupus erythematosus
- (2020) George C. Tsokos NATURE IMMUNOLOGY
- Update οn the diagnosis and management of systemic lupus erythematosus
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials
- (2020) Yoshiya Tanaka et al. Modern Rheumatology
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Binding mechanisms of therapeutic antibodies to human CD20
- (2020) Anand Kumar et al. SCIENCE
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
- (2019) Martin Aringer et al. Arthritis & Rheumatology
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
- (2018) Fengchun Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases
- (2016) Dana Saadeh et al. EXPERIMENTAL DERMATOLOGY
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
- (2015) Kate Franklyn et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Taming lupus—a new understanding of pathogenesis is leading to clinical advances
- (2012) Zheng Liu et al. NATURE MEDICINE
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Type I interferons in systemic autoimmunity
- (2010) Silvano Sozzani et al. AUTOIMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More